Literature DB >> 33605869

Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.

Carolina K V Nonaka, Marília Miranda Franco, Tiago Gräf, Camila Araújo de Lorenzo Barcia, Renata Naves de Ávila Mendonça, Karoline Almeida Felix de Sousa, Leila M C Neiva, Vagner Fosenca, Ana V A Mendes, Renato Santana de Aguiar, Marta Giovanetti, Bruno Solano de Freitas Souza.   

Abstract

Uncertainty remains about how long the protective immune responses against severe acute respiratory syndrome coronavirus 2 persists, and suspected reinfection in recovered patients has been reported. We describe a case of reinfection from distinct virus lineages in Brazil harboring the E484K mutation, a variant associated with escape from neutralizing antibodies.

Entities:  

Keywords:  Brazil; COVID-19; E484K spike mutation; SARS-CoV-2; coronavirus disease; genomic surveillance; reinfection; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Year:  2021        PMID： 33605869     DOI： 10.3201/eid2705.210191

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  74 in total

1.  Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil.

Authors:  Vinícius Bonetti Franceschi; Gabriel Dickin Caldana; Amanda de Menezes Mayer; Gabriela Bettella Cybis; Carla Andretta Moreira Neves; Patrícia Aline Gröhs Ferrareze; Meriane Demoliner; Paula Rodrigues de Almeida; Juliana Schons Gularte; Alana Witt Hansen; Matheus Nunes Weber; Juliane Deise Fleck; Ricardo Ariel Zimerman; Lívia Kmetzsch; Fernando Rosado Spilki; Claudia Elizabeth Thompson
Journal:  BMC Genomics       Date:  2021-05-20       Impact factor: 3.969

Review 2.  Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.

Authors:  Seyed Hamid Safiabadi Tali; Jason J LeBlanc; Zubi Sadiq; Oyejide Damilola Oyewunmi; Carolina Camargo; Bahareh Nikpour; Narges Armanfard; Selena M Sagan; Sana Jahanshahi-Anbuhi
Journal:  Clin Microbiol Rev       Date:  2021-05-12       Impact factor: 26.132

3.  Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil.

Authors:  Carolina M Voloch; Ronaldo da Silva Francisco; Luiz G P de Almeida; Cynthia C Cardoso; Otavio J Brustolini; Alexandra L Gerber; Ana Paula de C Guimarães; Diana Mariani; Raissa Mirella da Costa; Orlando C Ferreira; Thiago Silva Frauches; Claudia Maria Braga de Mello; Isabela de Carvalho Leitão; Rafael Mello Galliez; Débora Souza Faffe; Terezinha M P P Castiñeiras; Amilcar Tanuri; Ana Tereza R de Vasconcelos
Journal:  J Virol       Date:  2021-03-01       Impact factor: 5.103

4.  Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.

Authors:  Blake W Buchan; Joseph D Yao
Journal:  Clin Microbiol Newsl       Date:  2021-05-21

5.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.

Authors:  Manish C Choudhary; Charles R Crain; Xueting Qiu; William Hanage; Jonathan Z Li
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

6.  Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020.

Authors:  Paola Cristina Resende; João Felipe Bezerra; Romero Henrique Teixeira Vasconcelos; Ighor Arantes; Luciana Appolinario; Ana Carolina Mendonça; Anna Carolina Paixao; Ana Carolina Duarte; Thauane Silva; Alice Sampaio Rocha; Ana Beatriz Machado Lima; Alex Pauvolid-Corrêa; Fernando Couto Motta; Dalane Loudal Florentino Teixeira; Thiago Franco de Oliveira Carneiro; Francisco Paulo Freire Neto; Isabel Diniz Herbster; Anderson Brandao Leite; Irina Nastassja Riediger; Maria do Carmo Debur; Felipe Gomes Naveca; Walquiria Almeida; Mirian Livorati; Gonzalo Bello; Marilda M Siqueira
Journal:  Emerg Infect Dis       Date:  2021-04-22       Impact factor: 6.883

7.  The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.

Authors:  Richard Copin; Alina Baum; Elzbieta Wloga; Kristen E Pascal; Stephanie Giordano; Benjamin O Fulton; Anbo Zhou; Nicole Negron; Kathryn Lanza; Newton Chan; Angel Coppola; Joyce Chiu; Min Ni; Yi Wei; Gurinder S Atwal; Annabel Romero Hernandez; Kei Saotome; Yi Zhou; Matthew C Franklin; Andrea T Hooper; Shane McCarthy; Sara Hamon; Jennifer D Hamilton; Hilary M Staples; Kendra Alfson; Ricardo Carrion; Shazia Ali; Thomas Norton; Selin Somersan-Karakaya; Sumathi Sivapalasingam; Gary A Herman; David M Weinreich; Leah Lipsich; Neil Stahl; Andrew J Murphy; George D Yancopoulos; Christos A Kyratsous
Journal:  Cell       Date:  2021-06-05       Impact factor: 41.582

Review 8.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

Review 9.  SARS-CoV-2 one year on: evidence for ongoing viral adaptation.

Authors:  Thomas P Peacock; Rebekah Penrice-Randal; Julian A Hiscox; Wendy S Barclay
Journal:  J Gen Virol       Date:  2021-04       Impact factor: 3.891

10.  A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.

Authors:  Federico Bertoglio; Viola Fühner; Maximilian Ruschig; Philip Alexander Heine; Leila Abassi; Thomas Klünemann; Ulfert Rand; Doris Meier; Nora Langreder; Stephan Steinke; Rico Ballmann; Kai-Thomas Schneider; Kristian Daniel Ralph Roth; Philipp Kuhn; Peggy Riese; Dorina Schäckermann; Janin Korn; Allan Koch; M Zeeshan Chaudhry; Kathrin Eschke; Yeonsu Kim; Susanne Zock-Emmenthal; Marlies Becker; Margitta Scholz; Gustavo Marçal Schmidt Garcia Moreira; Esther Veronika Wenzel; Giulio Russo; Hendrikus S P Garritsen; Sebastian Casu; Andreas Gerstner; Günter Roth; Julia Adler; Jakob Trimpert; Andreas Hermann; Thomas Schirrmann; Stefan Dübel; André Frenzel; Joop Van den Heuvel; Luka Čičin-Šain; Maren Schubert; Michael Hust
Journal:  Cell Rep       Date:  2021-07-07       Impact factor: 9.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.